Literature DB >> 18675280

Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes.

Kaeko Nakayama1, Takeaki Nitto, Teruo Inoue, Koichi Node.   

Abstract

CYP2J2 is one of the cytochrome P450 epoxygenases involved in the metabolism of arachidonic acid. CYP2J2 has been identified in several tissues, especially cardiovascular tissues. CYP2J2 has cardiovascular effects, as epoxyeicosatrienoic acid, one of its metabolites, has anti-inflammatory and vasodilative activities. We investigated the expression of CYP2J2 in human leukocytes using reverse transcription-polymerase chain reaction, immunoblotting and immunostaining. Human monocytic cells, but not human neutrophils, exhibited constitutive expression of CYP2J2. Furthermore, the expression of CYP2J2 mRNA increased when the human monocytic cell line THP-1 cells and human monocytes were stimulated with phorbol 12-myristate 13-acetate and macrophage-colony stimulating factor in combination with granulocyte/macrophage-colony stimulating factor, respectively. These results suggest that expression of CYP2J2 was up-regulated when human monocytes differentiated into macrophages and that human monocytic cells and macrophages have a pathway to metabolize arachidonic acid using CYP epoxygenases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675280     DOI: 10.1016/j.lfs.2008.06.026

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  EET signaling in cancer.

Authors:  Dipak Panigrahy; Emily R Greene; Ambra Pozzi; Dao Wen Wang; Darryl C Zeldin
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction.

Authors:  Meiyan Dai; Lujin Wu; Zuowen He; Shasha Zhang; Chen Chen; Xizhen Xu; Peihua Wang; Artiom Gruzdev; Darryl C Zeldin; Dao Wen Wang
Journal:  J Cell Physiol       Date:  2015-09       Impact factor: 6.384

Review 3.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

Review 4.  Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.

Authors:  Dipak Panigrahy; Arja Kaipainen; Emily R Greene; Sui Huang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

Review 5.  Roles of the epoxygenase CYP2J2 in the endothelium.

Authors:  Ara Askari; Scott J Thomson; Matthew L Edin; Darryl C Zeldin; David Bishop-Bailey
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-03-06       Impact factor: 3.072

6.  Macrophage epoxygenase determines a profibrotic transcriptome signature.

Authors:  Ana Garcia Diaz; Lara Venda; Jeong-Hun Ko; Jacques Behmoaras; Prashant Srivastava; Alex Montoya; Peter Faull; Zoe Webster; Ben Moyon; Charles D Pusey; David J Abraham; Enrico Petretto; Terence H Cook; Timothy J Aitman
Journal:  J Immunol       Date:  2015-04-03       Impact factor: 5.422

7.  Inducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn's disease?

Authors:  Jonas Bystrom; Scott J Thomson; Jörgen Johansson; Matthew L Edin; Darryl C Zeldin; Derek W Gilroy; Andrew M Smith; David Bishop-Bailey
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

8.  sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions.

Authors:  Zhihui Chen; Ying Tang; Jing Yu; Ruolan Dong; Yan Yang; Menglu Fu; Jinlan Luo; Shuiqing Hu; Dao Wen Wang; Ling Tu; Xizhen Xu
Journal:  Shock       Date:  2020-06       Impact factor: 3.533

9.  Anti-inflammatory effects of epoxyeicosatrienoic acids.

Authors:  Scott J Thomson; Ara Askari; David Bishop-Bailey
Journal:  Int J Vasc Med       Date:  2012-07-16

10.  Azelnidipine Inhibits the Differentiation and Activation of THP-1 Macrophages through the L-Type Calcium Channel.

Authors:  Hiroshi Komoda; Aya Shiraki; Jun-Ichi Oyama; Toshiyuki Nishikido; Koichi Node
Journal:  J Atheroscler Thromb       Date:  2018-02-03       Impact factor: 4.928

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.